Evidence map›Paper›PMID 29696803›Full record

ReviewAmerican journal of medical genetics. Part A2018

X-linked intellectual disability update 2017.

Giovanni Neri, Charles E Schwartz, Herbert A Lubs, Roger E Stevenson

Abstract readReview
In one paragraph

Review in American journal of medical genetics. Part A, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Variable expression ofProceedings of the National Academy of Sciences of the United States of America · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Identification of a DLG3 stop mutation in the MRX20 family.European journal of human genetics : EJHG · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Giovanni NeriJ.C. Self Research Institute of Human Genetics, Greenwood Genetic Center, Greenwood, South Carolina.ORCID 0000-0001-7642-0130
Charles E SchwartzJ.C. Self Research Institute of Human Genetics, Greenwood Genetic Center, Greenwood, South Carolina.
Herbert A LubsJ.C. Self Research Institute of Human Genetics, Greenwood Genetic Center, Greenwood, South Carolina.
Roger E StevensonJ.C. Self Research Institute of Human Genetics, Greenwood Genetic Center, Greenwood, South Carolina.ORCID 0000-0002-1806-6345

Funding

Identification of Novel X-linked Intellectual Disability GenesR01NS073854 · NINDS · GREENWOOD GENETIC CENTER · PI SCHWARTZ, CHARLES E, WANG, TAO · 2011 to 2013
$1.4M
NINDS NIH HHS R01 NS073854
6 · The paper itself

Abstract

The X-chromosome comprises only about 5% of the human genome but accounts for about 15% of the genes currently known to be associated with intellectual disability. The early progress in identifying the X-linked intellectual disability (XLID)-associated genes through linkage analysis and candidate gene sequencing has been accelerated with the use of high-throughput technologies. In the 10 years since the last update, the number of genes associated with XLID has increased by 96% from 72 to 141 and duplications of all 141 XLID genes have been described, primarily through the application of high-resolution microarrays and next generation sequencing. The progress in identifying genetic and genomic alterations associated with XLID has not been matched with insights that improve the clinician's ability to form differential diagnoses, that bring into view the possibility of curative therapies for patients, or that inform scientists of the impact of the genetic alterations on cell organization and function.

Indexed as

Genes, X-LinkedAntigens, NuclearCell Cycle ProteinsChromosomes, Human, XCohesinsGene DuplicationGenetic TestingHumansIntellectual DisabilityMethyl-CpG-Binding Protein 2Myelin Proteolipid ProteinPhosphoric Monoester HydrolasesTumor Suppressor ProteinsUbiquitin-Protein LigasesAntigens, NuclearCell Cycle ProteinsCohesinsHUWE1 protein, humanMECP2 protein, humanMethyl-CpG-Binding Protein 2Myelin Proteolipid ProteinOCRL protein, humanPhosphoric Monoester HydrolasesPLP1 protein, humanSTAG2 protein, humanTumor Suppressor ProteinsUbiquitin-Protein Ligasesgenesintellectual disabilitysyndromeX-chromosomeXLID

Identifiers

PMID29696803
PMCPMC6049830

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.